HPV vaccine, adolescents, 2008–2012
↑Increase Desired
SOURCE: National Immunization Survey - Teen (NIS-Teen), CDC/NCIRD and CDC/NCHS.
NOTE: Data are for proportion of females aged 13-15 years receiving at least 3 doses of the quadrivalent or bivalent human papillomavirus (HPV) vaccine (objective IID-11.4) and the proportion of males aged 13-15 years receiving at least 3 doses of the quadrivalent HPV vaccine (objective IID-11.5).
The proportion of females aged 13-15 years who received at least 3 doses of the quadrivalent or bivalent human papillomavirus (HPV) vaccine increased 69.3% between 2008 and 2012, from 16.6% to 28.1%. The U.S. Advisory Committee on Immunization Practices (ACIP) began recommending the HPV vaccine among males in 2011. In 2012, 6.9% of males aged 13-15 years received at least 3 doses of the quadrivalent HPV vaccine.
Objective
IID-11.4
Revised
This objective was revised. See Revision History for Details.
Revised:
Monday, August 25, 2014
[@TODO: Fix this link] Read A User’s Guide to the National Snapshots
